Pfizer Inc. (NYSE:PFE) announced encouraging top-line data from a phase IIIb study evaluating Genotropin for increasing height in small-for-gestational-age (SGA) children aged between 24 and 30 months. Pfizer Inc. (NYSE:PFE) stock performance was -0.25% in last session and finished the day at $32.10. Traded volume was 27.74million shares in the last session and the average volume of the stock remained 26.63million shares. The beta of the stock remained 0.67. Pfizer Inc. (NYSE:PFE) insider ownership is 0.10%.

Gilead Sciences, Inc. (NASDAQ:GILD) announced that the company’s Marketing Authorization Application,MAA, for a once-daily fixed-dose combination of the NS5A inhibitor ledipasvir, LDV, 90 mg and the nucleotide analog polymerase inhibitor sofosbuvir, SOF, 400 mg for the treatment of chronic hepatitis C virus, HCV, genotype 1 infection, has been fully validated and is now under assessment by the European Medicines Agency, EMA. Gilead Sciences, Inc. (NASDAQ:GILD) dropped -1.88 percent to $71.41 Thursday on volume of 17.75million shares. The intra-day range of the stock was $70.59 to $73.34. Gilead Sciences, Inc. (NASDAQ:GILD) has a market capitalization of $108.82billion.

Inovio Pharmaceuticals Inc (NYSE:INO) was up, gaining 10.53 percent to $3.57 after the company received the “Best Theraputic Vaccine” award at the World Vaccine Congress after the close Wednesday. Inovio Pharmaceuticals Inc (NYSEMKT:INO)’s stock on Mar 27, 2014 reported a increase of 12.69% to the closing price of $3.64. Its fifty two weeks range is $0.49 -$3.95. The total market capitalization recorded $872.18million. The overall volume in the last trading session was 17.44million shares. In its share capital, INO has 208.86million outstanding shares.

Johnson & Johnson (NYSE:JNJ) had dismissed the destroyed documents as “inadvertent loss of certain, limited documents,” those fighting the company on the issue regarding pelvic implants accused of harming women have a different view. On Thursday, shares of Johnson & Johnson (NYSE:JNJ) advanced 0.24% to close the day at $97.28. Company return on investment (ROI) is 15.00% and its monthly performance is recorded as 6.77%. Johnson & Johnson (NYSE:JNJ) quarterly revenue growth is 6.43%.